Skip to main content


  • Correction
  • Open Access

Correction to: Protective and therapeutic role of 2-carbacyclic phosphatidic acid in demyelinating disease

  • 1,
  • 1,
  • 1,
  • 2,
  • 1,
  • 1,
  • 1,
  • 2 and
  • 1Email author
Journal of Neuroinflammation201815:67

  • Received: 22 February 2018
  • Accepted: 23 February 2018
  • Published:

The original article was published in Journal of Neuroinflammation 2017 14:142


After publication of the article [1], it was brought to our attention that an acknowledgement was missing from the original version. The authors would also like to include “We appreciate that Dr. Yoshibumi Shimizu at Ochanomizu University for sharing with us his preliminary experimental results about 2ccPA in the mouse brain following intraperitoneal administration”.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Department of Pharmacology, Faculty of Medicine, Saitama Medical University, 38 Moro-hongo, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
Endowed Research Division of Human Welfare Sciences, Ochanomizu University, 2-1-1 Ohtsuka, Bunkyo-ku, Tokyo 112-8610, Japan


  1. Yamamoto S, Yamashina K, Ishikawa M, Gotoh M, Yagishita S, Iwasa K, et al. Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease. J Neuroinflammation. 2017;14(1)


© The Author(s). 2018